Literature DB >> 9736474

Why does the myocardium fail? Insights from basic science.

M R Bristow1.   

Abstract

Mesh：

Year:  1998        PMID： 9736474     DOI： 10.1016/s0140-6736(98)90311-7

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  34 in total

1.  The role of cardiac imaging in optimizing therapy in heart failure.

Authors:  A Lahiri
Journal:  J Nucl Cardiol       Date:  2000 Jan-Feb       Impact factor: 5.952

2.  Preservation of myocardial beta-adrenergic receptor signaling delays the development of heart failure after myocardial infarction.

Authors:  D C White; J A Hata; A S Shah; D D Glower; R J Lefkowitz; W J Koch
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

Review 3.  Specific PI3K isoform modulation in heart failure: lessons from transgenic mice.

Authors:  Alessandra Ghigo; Fulvio Morello; Alessia Perino; Federico Damilano; Emilio Hirsch
Journal:  Curr Heart Fail Rep       Date:  2011-09

Review 4.  Novel Left Ventricular Assist System: an electrocardiogram-synchronized LVAS that avoids cardiac cannulation.

Authors:  Domingo Liotta
Journal:  Tex Heart Inst J       Date:  2003

5.  Polymorphisms of cardiac presynaptic alpha2C adrenergic receptors: Diverse intragenic variability with haplotype-specific functional effects.

Authors:  Kersten M Small; Jeanne Mialet-Perez; Carrie A Seman; Cheryl T Theiss; Kari M Brown; Stephen B Liggett
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-19       Impact factor: 11.205

Review 6.  Regulation of β-adrenergic receptor function: an emphasis on receptor resensitization.

Authors:  Neelakantan T Vasudevan; Maradumane L Mohan; Shyamal K Goswami; Sathyamangla V Naga Prasad
Journal:  Cell Cycle       Date:  2011-11-01       Impact factor: 4.534

7.  Sarcoplasmic reticulum function and carnitine palmitoyltransferase-1 inhibition during progression of heart failure.

Authors:  H Rupp; R Vetter
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

Review 8.  Drugs for cardiovascular risk reduction in the diabetic patient.

Authors:  D S Bell
Journal:  Curr Diab Rep       Date:  2001-10       Impact factor: 4.810

9.  A GRK5 polymorphism that inhibits beta-adrenergic receptor signaling is protective in heart failure.

Authors:  Stephen B Liggett; Sharon Cresci; Reagan J Kelly; Faisal M Syed; Scot J Matkovich; Harvey S Hahn; Abhinav Diwan; Jeffrey S Martini; Li Sparks; Rohan R Parekh; John A Spertus; Walter J Koch; Sharon L R Kardia; Gerald W Dorn
Journal:  Nat Med       Date:  2008-04-20       Impact factor: 53.440

10.  Molecular pathogenetic mechanisms and new therapeutic perspectives in anthracycline-induced cardiomyopathy.

Authors:  Giuseppe Distefano
Journal:  Ital J Pediatr       Date:  2009-11-20       Impact factor: 2.638
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.